Hawa G - Search Results

1

Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women.

Prezelj J, Ostanek B, Logar DB, Marc J, Hawa G, Kocjan T. Prezelj J, et al. Among authors: hawa g. Menopause. 2008 Mar-Apr;15(2):369-73. doi: 10.1097/gme.0b013e3181271873. Menopause. 2008. PMID: 17882010

2

Serum levels of cathepsin K decrease with age in both women and men.

Kerschan-Schindl K, Hawa G, Kudlacek S, Woloszczuk W, Pietschmann P. Kerschan-Schindl K, et al. Among authors: hawa g. Exp Gerontol. 2005 Jun;40(6):532-5. doi: 10.1016/j.exger.2005.04.001. Exp Gerontol. 2005. PMID: 15935595

3

The imbalance between osteoprotegerin and cathepsin K in the serum of patients with longstanding rheumatoid arthritis.

Skoumal M, Haberhauer G, Kolarz G, Hawa G, Woloszczuk W, Klingler A, Varga F, Klaushofer K. Skoumal M, et al. Among authors: hawa g. Rheumatol Int. 2008 May;28(7):637-41. doi: 10.1007/s00296-007-0506-3. Epub 2007 Dec 13. Rheumatol Int. 2008. PMID: 18075741

4

Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction.

Skoumal M, Haberhauer G, Kolarz G, Hawa G, Woloszczuk W, Klingler A. Skoumal M, et al. Among authors: hawa g. Arthritis Res Ther. 2005;7(1):R65-70. doi: 10.1186/ar1461. Epub 2004 Nov 10. Arthritis Res Ther. 2005. PMID: 15642144 Free PMC article.

5

Immunoassay for soluble RANKL (receptor activator of NF-kappaB ligand) in serum.

Hawa G, Brinskelle-Schmal N, Glatz K, Maitzen S, Woloszczuk W. Hawa G, et al. Clin Lab. 2003;49(9-10):461-3. Clin Lab. 2003. PMID: 14572201

6

Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass.

Anastasilakis AD, Polyzos SA, Makras P, Rauner M, Sonnleitner L, Hawa G, Tsourdi E, Yavropoulou MP, Missbichler A, Terpos E. Anastasilakis AD, et al. Among authors: hawa g. J Musculoskelet Neuronal Interact. 2019 Sep 1;19(3):253-257. J Musculoskelet Neuronal Interact. 2019. PMID: 31475931 Free PMC article.

7

Bisphosphonate treatment does not affect serum levels of osteoprotegerin and RANKL in hypercalcemic cancer patients.

Zojer N, Brenner K, Beke D, Kudlacek S, Hawa G, Woloszczuk W, Hofbauer LC, Pecherstorfer M. Zojer N, et al. Among authors: hawa g. Anticancer Res. 2005 Sep-Oct;25(5):3607-12. Anticancer Res. 2005. PMID: 16101188 Free article. Clinical Trial.

8

Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study.

Szulc P, Hawa G, Boutroy S, Vilayphiou N, Schoppet M, Chapurlat R, Hofbauer LC. Szulc P, et al. Among authors: hawa g. J Clin Endocrinol Metab. 2011 Jul;96(7):2216-26. doi: 10.1210/jc.2010-2617. Epub 2011 May 11. J Clin Endocrinol Metab. 2011. PMID: 21565793

9

Enzyme immunoassays for fragments (epitopes) of human proatrial natriuretic peptides.

Hartter E, Khalafpour S, Missbichler A, Hawa G, Woloszczuk W. Hartter E, et al. Among authors: hawa g. Clin Chem Lab Med. 2000 Jan;38(1):27-32. doi: 10.1515/CCLM.2000.005. Clin Chem Lab Med. 2000. PMID: 10774958

10

Sandwich ELISA for proANP 1-98 facilitates investigation of left ventricular dysfunction.

Missbichler A, Hawa G, Schmal N, Woloszczuk W. Missbichler A, et al. Among authors: hawa g. Eur J Med Res. 2001 Mar 26;6(3):105-11. Eur J Med Res. 2001. PMID: 11309223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters